Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Agilent Technologies discusses the incorporation of targeted single-cell multi-omics to complement their product portfolio


Kevin Corcoran
Aaron Llanso

Description

Kevin Corcoran, Vice President of Agilent Technologies, discusses the incorporation of targeted single-cell multi-omics to complement Agilent’s product portfolio and provide a more comprehensive oncology offering. He hosts Aaron Llanso of Mission Bio, who presents case studies on the use of single-cell sequencing in hematology, solid tumors, and gene editing.



VIEW


Scientific presentation
Unleashing the Potential of CRISPR & Navigating Heterogeneity in Genome Editing Outcomes
Travis Hardcastle, Synthego
Brittany Enzmann, Mission Bio
(2024)
Scientific presentation
From Cells to Cures: Panel Discussion on Advancing Clonal Profiling in Leukemia & Myeloma With Single-Cell Multiomics
Hervé Avet-Loiseau, MD, PhD
Felipe Prósper, MD, PhD
Cedric Dos Santos, PhD
Todd Druley, MD, PhD
(2023)
Scientific presentation
Single Cell Multi-Omics & the MRD Horizon
Todd Druley, MD, PhD
Blake Alexander
(2023)
Scientific presentation
Myeloma Matters: Advancing Research and Therapy Development with Single-cell DNA + Protein Multi-Omics
Todd Druley, MD, PhD
Adam Sciambi, PhD
(2023)
REQUEST QUOTE